Close this search box.

What Is The FDA Thinking?

new study shows that the RSV vaccine that was approved for pregnant women has a high incidence of causing pre-term birth.

We already knew this from clinical trials but the FDA voted to approve it anyway. We also knew that it increased risk of maternal death and that the immunity from the vaccine only lasted 30 days.

But is it helping to prevent RSV deaths? We don’t know because the results for the clinical trials were not published, despite being completed in October of 2023.

Related Articles

Join the mailing list

Get the daily email that makes reading the investment news actually enjoyable.

Related Articles

Redacted is an independent platform, unencumbered by external factors or restrictive policies, on which Clayton and Natali Morris bring you quality information, balanced reporting, constructive debate, and thoughtful narratives.